Evidence map›Paper›PMID 37161470›Full record

ArticleThe Journal of clinical endocrinology and metabolism2023

Resistance Exercise Counteracts the Impact of Androgen Deprivation Therapy on Muscle Characteristics in Cancer Patients.

Maarten Overkamp, Lisanne H P Houben, Thorben Aussieker, Janneau M X van Kranenburg, Philippe J M Pinckaers, Ulla R Mikkelsen, Milou Beelen, Sandra Beijer, Luc J C van Loon, Tim Snijders

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Influence of androgen deprivation therapy on physical performance and muscle strength in prostate cancer patients - a systematic review.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Maarten OverkampNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0003-1363-6414
Lisanne H P HoubenNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0001-8543-282X
Thorben AussiekerNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0002-5220-6938
Janneau M X van KranenburgNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.
Philippe J M PinckaersNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0003-0657-6505
Ulla R MikkelsenDepartment of Nutrition & Health, Research & Development, Arla Foods Ingredients Group P/S, Viby J, 8260, Denmark.ORCID 0000-0002-5410-8637
Milou BeelenNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0002-0065-1167
Sandra BeijerDepartment of Research & Development, Netherlands Comprehensive Cancer Organisation, Utrecht, 3511 DT, the Netherlands.ORCID 0000-0002-2510-8179
Luc J C van LoonNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0002-6768-9231
Tim SnijdersNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, 6200 MD, the Netherlands.ORCID 0000-0002-5874-1245
Maastricht University Medical Centre · NLArla Foods (Denmark) · DKTiFN · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAndrogen deprivation therapy (ADT) forms the cornerstone in prostate cancer (PCa) treatment. However, ADT also lowers skeletal muscle mass.

objectiveTo identify the impact of ADT with and without resistance exercise training on muscle fiber characteristics in PCa patients.

methodsTwenty-one PCa patients (72 ± 6 years) starting ADT were included. Tissue samples from the vastus lateralis muscle were assessed at baseline and after 20 weeks of usual care (n = 11) or resistance exercise training (n = 10). Type I and II muscle fiber distribution, fiber size, and myonuclear and capillary contents were determined by immunohistochemistry.

resultsSignificant decreases in type I (from 7401 ± 1183 to 6489 ± 1293 μm2, P < .05) and type II (from 6225 ± 1503 to 5014 ± 714 μm2, P < .05) muscle fiber size were observed in the usual care group. In addition, type I and type II individual capillary-to-fiber ratio (C/Fi) declined (-12% ± 12% and -20% ± 21%, respectively, P < .05). In contrast, significant increases in type I (from 6700 ± 1464 to 7772 ± 1319 μm2, P < .05) and type II (from 5248 ± 892 to 6302 ± 1385 μm2, P < .05) muscle fiber size were observed in the training group, accompanied by an increase in type I and type II muscle fiber myonuclear contents (+24% ± 33% and +21% ± 23%, respectively, P < .05) and type I C/Fi (+18% ± 14%, P < .05).

conclusionThe onset of ADT is followed by a decline in both type I and type II muscle fiber size and capillarization in PCa patients. Resistance exercise training offsets the negative impact of ADT and increases type I and II muscle fiber size and type I muscle fiber capillarization in these patients.

Indexed as

Prostatic NeoplasmsResistance TrainingAndrogen AntagonistsAndrogensExercise TherapyHumansMaleMuscle, SkeletalAndrogen AntagonistsAndrogensangiogenesisexercise rehabilitationolder adultsskeletal muscletestosterone

Identifiers

PMID37161470
PMCPMC10505531
OpenAlexW4376121435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.